Pivotal Therapeutics Inc. announced earnings results for the nine months ended September 30, 2015. For the period, the company reported an increase in sales of 88% to CAD 373,787 from CAD 198,867 in 2014. The company reported a decrease of 32% in net loss to CAD 3,706,876 from CAD 5,418,497 in 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0018 USD | +1,79,900.00% | -.--% | -.--% |
2016 | Pivotal Therapeutics Inc. Announces Management Changes | CI |
2015 | Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2L | |
+21.59% | 4.42TCr | |
+23.03% | 2.3TCr | |
+18.22% | 1.53TCr | |
+12.26% | 1.37TCr | |
+52.55% | 1.22TCr | |
-10.02% | 683.92Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.88% | 565.87Cr |
- Stock Market
- Equities
- PVTTF Stock
- News Pivotal Therapeutics Inc.
- Pivotal Therapeutics Inc. Announces Earnings Results for the Nine Months Ended September 30, 2015